GNH USA

Europe — EMA

Leflunomidă Sandoz

GNH USA supplies Leflunomidă Sandoz (Leflunomide), a immunomodulatory DMARD for rheumatoid arthritis and psoriatic arthritis.

Leflunomide

Request sourcing

1
Pack/s

What is Leflunomide?

Leflunomide, the active ingredient in Leflunomidă Sandoz, is an immunomodulatory DMARD presented as an oral formulation for oral use. It is indicated for the treatment of rheumatoid arthritis and psoriatic arthritis in adult patients.

GNH USA supplies Leflunomidă Sandoz as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

What is Leflunomide used for?

Leflunomide is used to manage autoimmune inflammatory conditions within the rheumatoid arthritis disease family.

Rheumatoid arthritis: reduces joint inflammation, pain and slows structural damage. Psoriatic arthritis: alleviates skin and joint symptoms and inhibits disease progression. Moderate to severe rheumatoid arthritis: improves functional ability and quality of life in adult patients.

What are the side effects of Leflunomide?

Leflunomidă Sandoz may cause a range of adverse reactions.

Common Side Effects: - Diarrhoea - Nausea or abdominal discomfort - Alopecia (hair loss) - Rash or mild skin irritation - Elevated liver enzymes - Hypertension

Serious or Rare Side Effects: - Severe liver injury or hepatitis - Bone marrow suppression leading to neutropenia or anemia - Pulmonary toxicity, including interstitial lung disease - Stevens‑Johnson syndrome or toxic epidermal necrolysis - Severe infections due to immunosuppression - Teratogenic effects causing fetal harm

What precautions apply to Leflunomide?

Before initiating therapy, clinicians should consider several safety measures.

Monitor liver function: obtain baseline and periodic liver enzyme tests. Monitor blood pressure: check regularly, especially in hypertensive patients. Avoid use in pregnancy: leflunomide is contraindicated (Category X). Avoid use while breastfeeding: drug may be excreted in milk. Use effective contraception: both male and female patients must use reliable methods. Store at below 25°C: keep in the original packaging, protect from moisture and direct sunlight.

What does Leflunomide interact with?

Leflunomide can interact with several medicines, requiring careful management.

Major Interactions (Avoid): - Warfarin: may increase INR and bleeding risk. - Statins (e.g., simvastatin): heightened risk of hepatotoxicity. - Azathioprine or other bone‑marrow suppressants: additive myelosuppression.

Moderate Interactions (Monitor Closely): - Methotrexate: potential additive liver toxicity. - NSAIDs: may exacerbate hepatic enzyme elevations. - Oral contraceptives: leflunomide can reduce contraceptive efficacy, requiring additional barrier methods.

Frequently asked questions

What is Leflunomidă Sandoz used for?+
Leflunomidă Sandoz contains leflunomide, an immunomodulatory disease‑modifying antirheumatic drug (DMARD) that is prescribed to treat adult patients with moderate to severe rheumatoid arthritis and psoriatic arthritis. It helps reduce joint inflammation, pain, and structural damage associated with these autoimmune conditions.
How does leflunomide work?+
Leflunomide works by inhibiting the enzyme dihydroorotate dehydrogenase, which is essential for de novo pyrimidine synthesis. This inhibition limits the proliferation of activated T‑lymphocytes, thereby decreasing the immune‑driven inflammatory response that contributes to joint damage in rheumatoid and psoriatic arthritis.
What is the usual dose of leflunomide?+
The dosage of leflunomide is individualized by the prescribing clinician based on the patient’s clinical status, laboratory values, and tolerance. Typically, treatment begins with a loading dose followed by a maintenance dose, but the exact regimen must be determined by a qualified healthcare professional.
Is leflunomide safe in pregnancy or breastfeeding?+
Leflunomide is classified as Pregnancy Category X, meaning it is contraindicated during pregnancy because it can cause fetal malformations and embryotoxicity. It is also not recommended for breastfeeding mothers, as the drug can be excreted in breast milk and may affect the infant.
How do I order Leflunomidă Sandoz from GNH USA?+
To order Leflunomidă Sandoz, submit an enquiry on the product page at gnh-usa.com, specifying the required quantity. GNH USA supplies hospitals, pharmacies, and procurement teams worldwide, and will request trade or institutional credentials. The team will then respond with pricing, availability, shipping details (including any required temperature control), and import documentation.
How does leflunomide compare with the main alternative drug or class?+
Leflunomide is often compared with methotrexate, another first‑line DMARD for rheumatoid arthritis. While both reduce disease activity, leflunomide has a distinct mechanism—blocking pyrimidine synthesis—whereas methotrexate inhibits folate metabolism. Leflunomide may be preferred in patients who cannot tolerate methotrexate’s hepatic or gastrointestinal side effects, but it carries its own risks such as hepatotoxicity and teratogenicity.
How should Leflunomidă Sandoz be stored and handled?+
Leflunomidă Sandoz should be stored at temperatures below 25 °C. Keep the tablets in the original container, protect them from moisture and direct sunlight, and ensure the packaging remains tightly closed until use. Do not store in a refrigerator or freezer, as this could affect tablet integrity.
How is Leflunomidă Sandoz given/ administered?+
Leflunomidă Sandoz is administered orally, usually as whole tablets swallowed with water. The exact dosing schedule, including any loading dose, is determined by the prescribing physician. Patients should follow the prescriber’s instructions and take the medication consistently at the same time each day to maintain stable drug levels.
What are the most serious risks to watch for while taking leflunomide?+
The most serious risks associated with leflunomide include severe liver injury, bone‑marrow suppression leading to neutropenia or anemia, pulmonary toxicity such as interstitial lung disease, and rare but life‑threatening skin reactions like Stevens‑Johnson syndrome. Patients should be monitored regularly for liver enzymes, blood counts, and respiratory symptoms.
Who should not use leflunomide?+
Leflunomide should not be used by individuals who are pregnant, planning to become pregnant, or are breastfeeding. It is also contraindicated in patients with severe hepatic impairment, active infections, or known hypersensitivity to leflunomide or its metabolites. Clinicians must assess each patient’s medical history before initiating therapy.
Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.

Product details

Drug
Leflunomide
Route
Oral Use
Manufacturer
Sandoz Pharmaceuticals S.R.L.
Origin
EU

Related products